Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
soneas.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About Soneas

Soneas is a contract development and manufacturing organization (CDMO) that provides comprehensive services from drug development to manufacturing.

Soneas Headquarter Location

Illatos út 33.

Budapest, H-1097,

Hungary

+36 1 347 5060

Latest Soneas News

India Dealbook: Elliott exits Cognizant; Vivimed unit acquires Hungarian firm

May 17, 2018

May 17, 2018 While activist hedge fund Elliott Management has exited technology major Cognizant, pharmaceutical company Vivimed Labs, through its unit UQUIFA, is acquiring Hungarian firm Soneas. Activist hedge fund Elliott Management exits Cognizant US-based activist hedge fund  Elliott Managemen t has exited  Cognizant reaping benefits from a 50 per cent rise in the stock price of the technology major over the last 18 months, according to a report in The Economic Times. Eliott Management is credited with having changed Cognizant’s business strategy a couple of years ago. In 2016, the investment firm disclosed that it had around 4 per cent stake in Cognizant and asked it to begin paying dividends, institute buybacks and shake up its board. Cognizant complied with those requests, beginning a $3.4-billion capital return programme and replacing three members of the board. A Cognizant executive told the newspaper that company’s strategy would not change following Elliott Management’s exit. It was recently reported that Elliot had picked up a small stake in Indian technology giant Wipro Ltd. Vivimed Labs’ unit acquires Hungarian firm Soneas Pharmaceutical company  Vivimed Labs is acquiring Hungarian contract development and manufacturing firm Soneas for an undisclosed amount. Vivimed Labs Spain S.L, the parent of UQUIFA S.A, has signed definitive agreements to facilitate the acquisition of Soneas, a contract development and manufacturing company, focused on the innovator pharma and fine chemical sectors. UQUIFA, the API business of Hyderabad-based Vivimed Labs, acquired the Soneas from Lochlomond and Euroventures which are both based out of Hungary. Also Read:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Soneas Patents

Soneas has filed 2 patents.

The 3 most popular patent topics include:

  • Coordination chemistry
  • Organometallic chemistry
  • Amines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/9/2016

5/14/2019

Stereochemistry, Amines, Organometallic chemistry, Coordination chemistry, Benzamides

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/9/2016

00/00/0000

Grant Date

5/14/2019

00/00/0000

Title

Subscribe to see more

Related Topics

Stereochemistry, Amines, Organometallic chemistry, Coordination chemistry, Benzamides

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.